[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![IDEAYA Biosciences, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$idya.png) IDEAYA Biosciences, Inc. Common Stock (IDYA)

IDEAYA Biosciences sees positive social media buzz with mentions up significantly. The stock price is up XXXX% in the last XX hours driven by investor interest in the company's cancer therapy pipeline.

### About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences, Inc. Common Stock (IDYA) is a healthcare sector stock focused on developing cancer therapies.  
IDEAYA Biosciences, Inc. Common Stock uses the ticker $IDYA for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$idya/insights)
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements hit XXXXXX which is XXX% higher than it's daily average.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) trading volume is up XXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) market cap is up XXXXX% from the previous X months.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) social dominance is up XXXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) galaxy score™ is up XXXXXX% from the previous X months.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) sentiment is up XXXXX% from the previous X months.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) engagements is up XXXXX% from the previous week.
- IDEAYA Biosciences, Inc. Common Stock (IDYA) posts created is up XXXXXX% from the previous week.

### Price: $XXXXX [#](/topic/$idya/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$idya/time-series/close.tsv)  
The current price increase of XXXX% in the last XX hours is likely due to positive analyst ratings, supportive social sentiment, and investor confidence in the company's cancer therapy pipeline, especially with the upcoming ESMO update.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| XXXX%   | XXXXX% | XXXXX% |

**1-Year High**: $XX on 2024-11-11  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$idya/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$idya/time-series/alt_rank.tsv)  
IDEAYA Biosciences, Inc. Common Stock (IDYA) is currently AltRank #289 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX +128  
**6 Months**: XXX +207  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-08-29  
**1-Year Low**: XX on 2025-01-11  
  
  
### Galaxy Score: XX [#](/topic/$idya/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$idya/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX +25  
**1 Month**: XX +19  
**6 Months**: XX +1  
**1 Year**: XX +23  
**1-Year High**: XX on 2025-07-24  
**1-Year Low**: X on 2025-06-11  
  
  
### Engagements: XXXXXX [#](/topic/$idya/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$idya/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXXX +65%  
**1 Month**: XXXXXXX -X%  
**6 Months**: XXXXXXXXX -XXXX%  
**1 Year**: XXXXXXXXX +49%  
**1-Year High**: XXXXXX on 2024-10-25  
**1-Year Low**: XXX on 2025-05-10  

| Social Network | X      | YouTube |
| -------------- | -      | ------- |
| Engagements    | XXXXXX | XX      |
  

  
  
### Mentions: XX [#](/topic/$idya/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$idya/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXXXX -XXXX%  
**1 Year**: XXXXX +109%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2024-10-21  

| Social Network | X  | YouTube |
| -------------- | -  | ------- |
| Mentions       | XX | X       |
  

  
  
### Creators: XX [#](/topic/$idya/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$idya/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning IDEAYA Biosciences, Inc. Common Stock (IDYA) in the last XX hours which is down XXXX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**6 Months**: XXX +91%  
**1 Year**: XXXXX +164%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: X on 2025-06-01  

The most influential creators that mention IDEAYA Biosciences, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXXX      |
| [@Brad_E_Schulz](/creator/twitter/Brad_E_Schulz)     | X    | XXXXXX    | X     | XXXXX       |
| [@A1PHAEDGE](/creator/twitter/A1PHAEDGE)             | X    | XXX       | XX    | XXX         |
| [@TOWiU2](/creator/twitter/TOWiU2)                   | X    | XXXXX     | X     | XXX         |
| [@bioinvestor24](/creator/twitter/bioinvestor24)     | X    | XXXXX     | X     | XXX         |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXX         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)       | X    | XXXXX     | X     | XXX         |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | X     | XXX         |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@Biobeats99](/creator/twitter/Biobeats99)           | XX   | XXX       | X     | XXX         |

[View More](/list/creators/$idya/100)
  
  
### Sentiment: XX% [#](/topic/$idya/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$idya/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +20%  
**1 Month**: XXX% +14%  
**6 Months**: XXX% +46%  
**1 Year**: XXX% +17%  
**1-Year High**: XXX% on 2024-10-21  
**1-Year Low**: XX% on 2025-02-04  

**Most Supportive Themes**
- **Positive Outlook on Pipeline and Potential Blockbuster Drugs:** (45%) Posts highlight the potential of IDEAYA's pipeline, particularly its Uveal Melanoma drug and DLL3 programs, with expectations of significant market impact.
- **Analyst Ratings and Price Targets:** (25%) Positive analyst ratings from Barclays and Citizens, with price targets of $XX and $XX respectively, are mentioned, indicating confidence in the stock's future performance.
  
**Most Critical Themes**
- **General Market Volatility and Biotech Sector Performance:** (10%)  Some posts acknowledge the inherent volatility in the biotech sector and the importance of monitoring overall market trends.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXXX  | XX% | X        | X% |
| YouTube | XX       | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXXX  | XX% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$idya/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$idya/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXX% +0.027%  
**1 Month**: XXXXXX% +0.005%  
**6 Months**: XXXXXX% -XXXXX%  
**1 Year**: XXXXXX% +0.0012%  
**1-Year High**: XXXXX% on 2024-11-20  
**1-Year Low**: XXXXXX% on 2025-09-23  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$idya/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$idya/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2024-11-06  
**1-Year Low**: XXXXXXX% on 2025-03-19  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$idya/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$idya/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$idya/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$18%  
**1 Month**: $XXXXXXXXXXXXX +$12%  
**6 Months**: $XXXXXXXXXXXXX +$61%  
**1 Year**: $XXXXXXXXXXXXX -$0.61%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-11-11  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about IDEAYA Biosciences, Inc. Common Stock in the last XX hours

[Landwolf (WOLF)](/topic/$wolf)
[DeFi Development Corp. (DFDV)](/topic/defi-development-corp)
[Cytokinetics Inc. (CYTK)](/topic/$cytk)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[YETI Holdings, Inc. Common Stock (YETI)](/topic/$yeti)
[Realty Income Corp (O)](/topic/realty-income-corp)

**Top topics mentioned**
In the posts about IDEAYA Biosciences, Inc. Common Stock in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$zlab](/topic/$zlab), [$wolf](/topic/$wolf), [defi development corp](/topic/defi-development-corp), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$cytk](/topic/$cytk), [$amgn](/topic/$amgn), [gilead sciences](/topic/gilead-sciences), [stocks energy](/topic/stocks-energy), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$rapp](/topic/$rapp), [$yeti](/topic/$yeti), [realty income corp](/topic/realty-income-corp), [stocks real estate](/topic/stocks-real-estate), [$imte](/topic/$imte), [acquisition](/topic/acquisition), [$evax](/topic/$evax), [$lqda](/topic/$lqda), [$dfdv](/topic/$dfdv), [$vktx](/topic/$vktx), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$srpt](/topic/$srpt), [$apge](/topic/$apge), [$rvmd](/topic/$rvmd), [stocks technology](/topic/stocks-technology), [$9688hk](/topic/$9688hk), [investment](/topic/investment), [$bbio](/topic/$bbio), [$agio](/topic/$agio), [$bmrn](/topic/$bmrn), [$kura](/topic/$kura), [$gild](/topic/$gild), [$lbrt](/topic/$lbrt), [$nvs](/topic/$nvs), [$dnth](/topic/$dnth), [$trml](/topic/$trml), [$110golden](/topic/$110golden), [coins base ecosystem](/topic/coins-base-ecosystem), [coins arbitrum](/topic/coins-arbitrum), [$axsm](/topic/$axsm), [send this](/topic/send-this), [$ptgx](/topic/$ptgx), [$dcth](/topic/$dcth), [atai life](/topic/atai-life), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$mdgl](/topic/$mdgl), [$rna](/topic/$rna), [$abvx](/topic/$abvx), [novartis](/topic/novartis), [$novnsw](/topic/$novnsw), [$cdtx](/topic/$cdtx), [$incy](/topic/$incy), [$prgo](/topic/$prgo), [$cort](/topic/$cort), [$arwr](/topic/$arwr), [$insm](/topic/$insm), [$crnx](/topic/$crnx), [$alks](/topic/$alks), [$dnli](/topic/$dnli), [hosting](/topic/hosting), [topics](/topic/topics), [$imcr](/topic/$imcr), [bmy](/topic/bmy), [$smmt](/topic/$smmt), [$sats](/topic/$sats), [alibaba group](/topic/alibaba-group), [coins defi](/topic/coins-defi), [$jazz](/topic/$jazz), [$inbx](/topic/$inbx), [dec](/topic/dec), [$betr](/topic/$betr), [$ebc](/topic/$ebc), [$cof](/topic/$cof), [$zgn](/topic/$zgn), [china](/topic/china), [amgn](/topic/amgn), [$rhhby](/topic/$rhhby), [combo](/topic/combo), [$stml](/topic/$stml), [$ctic](/topic/$ctic), [$next](/topic/$next), [$tikr](/topic/$tikr), [sealed air corp](/topic/sealed-air-corp), [$see](/topic/$see), [$qure](/topic/$qure), [$ntla](/topic/$ntla), [vivo](/topic/vivo), [money](/topic/money), [$xbis](/topic/$xbis), [$nktr](/topic/$nktr), [stocks basic materials](/topic/stocks-basic-materials), [$rdnt](/topic/$rdnt), [$celc](/topic/$celc), [$atai](/topic/$atai), [amsterdam](/topic/amsterdam), [os](/topic/os), [compliance](/topic/compliance), [$kodk](/topic/$kodk)

### Top Social Posts [#](/topic/$idya/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Yata's $NVS pedigree and brilliant discovery platforms currently w X clinical stage programs make it likely $IDYA swallowed whole by BP ( Novartis/ $RHHBY). Almost a billion in cash"  
[X Link](https://x.com/princetongb/status/1979576282699456745) [@princetongb](/creator/x/princetongb) 2025-10-18T15:52Z 4851 followers, 1037 engagements


"Grok for the purposes of continuing due diligence tell me about the business plan pipeline most valuable asset the management and investors in Ideaya Biosciences $IDYA"  
[X Link](https://x.com/JamesEKrause/status/1979549315434770694) [@JamesEKrause](/creator/x/JamesEKrause) 2025-10-18T14:05Z 13.2K followers, 1343 engagements


"🧬 Biopharma Weekly Recap 📝 This week in biotech: Gene therapy and CRISPR roar back as $QURE M&A chatter heats up $NTLA leads in vivo race institutional money piles into GLP-1 giants and $XBIs rally signals sector revival. See interesting posts/ppl to check out 👇 @ericjackson 💊 Rate Cuts. Risk On. Biotech Reawakens. $SANA Looks Like the Next 100-Bagger Platform. @yaireinhorn BioTech & Pharma rebound: $XBI +9.5% since Sept XX +16.6% YTD. Recovery looks real but IPOs will be the true test. @mikeaxolotl Thesis: $QURE will be acquired for $8.5-11.4B+ within 6-18 months. That's 138-200%+ upside"  
[X Link](https://x.com/BiopharmIQ/status/1979539567184347239) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-18T13:26Z 27.4K followers, 8295 engagements


"$IDYA Big green day $11.8K profit locked 💰 Stop missing out on winning tradesstart your free trial now👇 Check here:"  
[X Link](https://x.com/Elisabe66802172/status/1979536988706406721) [@Elisabe66802172](/creator/x/Elisabe66802172) 2025-10-18T13:16Z XXX followers, XX engagements